arrow
E

Elena Campione

University of Rome Tor Vergata
H指数:37
被引数:5,142

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genetic Markers of Tumor Multiplicity in Non-melanoma Skin Cancer: Associations of 19 SNPs in an Italian Cohort

非黑色素瘤皮肤癌中肿瘤多发性遗传标记:意大利队列中19个SNP的关联

2026-04-110
OAAI
A de novo KCNA3 and an inherited KCNQ3 missense variant causing a developmental and epileptic encephalopathy, intellectual disability, and behavioral anomalies

新生KCNA3基因和遗传性KCNQ3基因错义变异导致发育性癫痫性脑病、智力障碍和行为异常

2026-01-300
PRE
Modelling severe COVID-19 in TLR3-mutated hiPSCs-derived lung organoids

在TLR3突变的hiPSCs来源的肺类器官中模拟重症COVID-19

2025-12-260
OAAI
Non-Invasive Imaging to Detect the Effects of Topical N-Butanoyl Glutathione (GSH-C4) and Hyaluronic Acid in Inflammatory Eczematous Dermatitis

非侵入性成像检测外用N-丁酰谷胱甘肽(GSH-C4)和透明质酸在炎症性湿疹样皮炎中的效果

2025-12-110
OAAI
Efficacy and Safety of Glycopyrronium Bromide 1% Cream in Axillary and Extra-Axillary Primary Hyperhidrosis: A Real-Life Two-Center Experience on 68 Subjects

格鲁匹罗尼溴化物1%乳膏在腋窝和非腋窝原发性多汗症中的疗效与安全性:一项基于68例患者的真实世界双中心经验研究

2025-08-290
OAAI
Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation-IL PSO (Italian Landscape Psoriasis)

度普利尤单抗治疗中重度银屑病的强应答者特征:一项短期真实世界观察-IL PSO(意大利银屑病全景研究)

2025-05-150
OAAI
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis)

银屑病患者中性别对Bimekizumab应答的影响:IL PSO(意大利银屑病景观)真实世界多中心回顾性研究的结果

2025-05-130
OA
Evaluating the Efficacy of Bimekizumab across the Different Sensitive Areas in Moderate-to-Severe Psoriasis: A 52-week Italian Multicenter Real-Life Lazio Experience

评估Bimekizumab在不同敏感区域治疗中重度银屑病的疗效:一项为期52周的意大利多中心真实世界拉齐奥经验

2025-04-110
OA
Trends in Precision Medicine and Pharmacogenetics as an Adjuvant in Establishing a Correct Immunosuppressive Therapy for Kidney Transplant: An Up-to-Date Historical Overview

精准医学和药物基因组学作为辅助手段,在建立正确的肾移植免疫抑制疗法中的应用趋势:一个最新的历史概述

2025-02-240
OA
Effectiveness of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: A Retrospective, Real-World Multicenter Study with a Focus on Obese and Multi-Failure Patients-IL PSO (Italian Landscape Psoriasis)
2025-02-080
OAAI
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study

Bimekizumab在指甲牛皮癣中的快速临床反应: 一项为期36周的回顾性多中心现实生活研究

2024-10-162
OAAI